Aldosterone blunts tubuloglomerular feedback by activating macula densa mineralocorticoid receptors

Hypertension

Volumn 59, Issue 3, 2012, Pages 599-606

  Fu, Yiling ^a   Hall, John E ^a   Lu, Deyin ^a   Lin, Lin ^a   Manning, R Davis ^a   Cheng, Liang ^a   Gomez Sanchez, Celso E ^b   Juncos, Luis A ^a   Liu, Ruisheng ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

aldosterone; mineralocorticoid receptor; nitric oxide; tubuloglomerular feedback

Indexed keywords

ALDOSTERONE; EPLERENONE; MINERALOCORTICOID RECEPTOR; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; EXPERIMENTAL RABBIT; GLOMERULUS FILTRATION RATE; IMMUNOFLUORESCENCE; JUXTAGLOMERULAR APPARATUS; KIDNEY; KIDNEY DISTAL TUBULE; KIDNEY TUBULOGLOMERULAR FEEDBACK; LASER CAPTURE MICRODISSECTION; MACULA DENSA; MALE; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; RAT; RENAL SYSTEM PARAMETERS;

ALDOSTERONE; ANIMALS; CELLS, CULTURED; FEEDBACK; GLOMERULAR FILTRATION RATE; JUXTAGLOMERULAR APPARATUS; KIDNEY TUBULES, DISTAL; MALE; NITRIC OXIDE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MINERALOCORTICOID;

EID: 84857634292     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.173195     Document Type: Article

References (34)

1. Funder JW. The nongenomic actions of aldosterone. Endocr Rev. 2005; 26:313-321. (Pubitemid 40686645)
2. Hall JE, Granger JP, Smith MJ Jr, Premen AJ. Role of renal hemodynamics and arterial pressure in aldosterone "escape." Hypertension. 1984; 6:I183-I192.
3. Kimura G, Uzu T, Nakamura S, Inenaga T, Fujii T. High sodium sensitivity and glomerular hypertension/hyperfiltration in primary aldosteronism. J Hypertens. 1996;14:1463-1468. (Pubitemid 27007817)
4. Ribstein J, du CG, Fesler P, Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol. 2005;16:1320-1325. (Pubitemid 41716516)
5. de Paula RB, da Silva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension. 2004;43:41-47. (Pubitemid 38031909)
6. Liu R, Ren Y, Garvin JL, Carretero OA. Superoxide enhances tubuloglomerular feedback by constricting the afferent arteriole. Kidney Int. 2004; 66:268-274. (Pubitemid 38870102)
7. Wilcox CS, Welch WJ. TGF and nitric oxide: effects of salt intake and salt-sensitive hypertension. Kidney Int. 1996;55:S9-S13.
8. Zhang R, Harding P, Garvin JL, Juncos R, Peterson E, Juncos LA, Liu R. Isoforms and functions of NADPH oxidase at the macula densa. Hypertension. 2009;53:556-563.
9. Gomez-Sanchez CE, de Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT, Gomez-Sanchez EP. Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology. 2006;147:1343-1348. (Pubitemid 43244368)
10. Zhu X, Manning RD Jr, Lu D, Gomez-Sanchez CE, Fu Y, Juncos LA, Liu R. Aldosterone stimulates superoxide production in macula densa cells. Am J Physiol Renal Physiol. 2011;301:F529-F535.
11. Vandewalle A, Farman N, Bencsath P, Bonvalet JP. Aldosterone binding along the rabbit nephron: an autoradiographic study on isolated tubules. Am J Physiol. 1981;240:F172-F179. (Pubitemid 11139563)
12. Lombès M, Farman N, Oblin ME, Baulieu EE, Bonvalet JP, Erlanger BF, Gasc JM. Immunohistochemical localization of renal mineralocorticoid receptor by using an anti-idiotypic antibody that is an internal image of aldosterone. Proc Natl Acad Sci U S A. 1990;87:1086-1088.
13. Todd-Turla KM, Schnermann J, Fejes-Toth G, Naray-Fejes-Toth A, Smart A, Killen PD, Briggs JP. Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron. Am J Physiol. 1993; 264:F781-F791. (Pubitemid 23149705)
14. Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol. 2006;17:3438-3446. (Pubitemid 44865286)
15. Arima S, Kohagura K, Xu HL, Sugawara A, Abe T, Satoh F, Takeuchi K, Ito S. Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol. 2003;14:2255-2263. (Pubitemid 37052371)
16. Arima S, Kohagura K, Xu HL, Sugawara A, Uruno A, Satoh F, Takeuchi K, Ito S. Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole. Hypertension. 2004;43:352-357. (Pubitemid 38174138)
17. Uhrenholt TR, Schjerning J, Hansen PB, Norregaard R, Jensen BL, Sorensen GL, Skott O. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ Res. 2003;93:1258-1266. (Pubitemid 37547959)
18. Schmidt BM, Oehmer S, Delles C, Bratke R, Schneider MP, Klingbeil A, Fleischmann EH, Schmieder RE. Rapid nongenomic effects of aldosterone on human forearm vasculature. Hypertension. 2003;42:156-160. (Pubitemid 36944589)
19. Ganong WF, Mulrow PJ. Rate of change in sodium and potassium excretion after injection of aldosterone into the aorta and renal artery of the dog. Am J Physiol. 1958;195:337-342.
20. Fujii Y, Takemoto F, Katz AI. Early effects of aldosterone on Na-K pump in rat cortical collecting tubules. Am J Physiol. 1990;259:F40-F45. (Pubitemid 20246414)
21. + exchange and raises cytoplasmic pH in target cells of the amphibian kidney. Proc Natl Acad Sci U S A. 1987;84:1464-1468. (Pubitemid 17027375)
22. + conductance in response to aldosterone. J Membr Biol. 1989;111: 49-56. (Pubitemid 19239502)
23. 2+ and stimulation of a plasma membrane proton conductance. Proc Natl Acad Sci U S A. 1996;93:10500-10504.
24. Gekle M, Silbernagl S, Oberleithner H. The mineralocorticoid aldosterone activates a proton conductance in cultured kidney cells. Am J Physiol. 1997;273:C1673-C1678.
25. +-exchange in MDCK cells by aldosterone involves MAP-kinase ERK1/2. Pflugers Arch. 2001;441: 781-786. (Pubitemid 32186544)
26. Good DW, George T, Watts BA III. Aldosterone inhibits HCO absorption via a nongenomic pathway in medullary thick ascending limb. Am J Physiol Renal Physiol. 2002;283:F699-F706. (Pubitemid 35033957)
27. Sheader EA, Wargent ET, Ashton N, Balment RJ. Rapid stimulation of cyclic AMP production by aldosterone in rat inner medullary collecting ducts. J Endocrinol. 2002;175:343-347. (Pubitemid 35414381)
28. Winter C, Schulz N, Giebisch G, Geibel JP, Wagner CA. Nongenomic stimulation of vacuolar H-ATPases in intercalated renal tubule cells by aldosterone. Proc Natl Acad Sci U S A. 2004;101:2636-2641. (Pubitemid 38269363)
29. Vallon V, Traynor T, Barajas L, Huang YG, Briggs JP, Schnermann J. Feedback control of glomerular vascular tone in nNOS knockout mice. J Am Soc Nephrol. 2001;12:1599-1606. (Pubitemid 32674421)
30. Ito S, Ren Y. Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest. 1993;92:1093-1098. (Pubitemid 23262435)
31. 2+ levels, and vasoconstriction in mesenteric resistance vessels. Endocrinology. 2005;146:973-980. (Pubitemid 40289282)
32. Schmidt BM, Sammer U, Fleischmann I, Schlaich M, Delles C, Schmieder RE. Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension. 2006;47:650-655. (Pubitemid 43740234)
33. Rad AK, Balment RJ, Ashton N. Rapid natriuretic action of aldosterone in the rat. J Appl Physiol. 2005;98:423-428. (Pubitemid 40129947)
34. Rocha R, Chander PN, Zuckerman A, Stier CT Jr. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension. 1999;33:232-237. (Pubitemid 29065665)